Status:
COMPLETED
Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Non-interventional, retrospective study of advanced SCLC patients in 4 European countries (France, Germany, Italy, and United Kingdom \[UK\]) with the aim to produce evidence across different SCLC tre...
Eligibility Criteria
Inclusion
- Cohort 1 and 2:
- Patients 18 years of age or older at SCLC diagnosis
- Confirmed diagnosis of SCLC within the patient identification period (between October 2013 and October 2015)
- Initiated on first-line treatment (radiotherapy and/or chemotherapy) for their SCLC
- Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first)
- Signed informed consent (where required as per local requirements)
- Cohort 3:
- Patients 18 years of age or older at SCLC diagnosis
- Confirmed diagnosis of SCLC not earlier than October 2013
- Initiated on second-line treatment due to relapse after first-line therapy not later than August 2016
- Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first)
- Signed informed consent (where required as per local requirements)
Exclusion
- Participants with previous malignancies (except non-melanoma skin cancers, and in situ cancers such as the following: bladder, gastric, colon, cervical/dysplasia, melanoma, or breast) are excluded unless a complete remission was achieved at least 2 years prior to first treatment and no additional therapy is required or anticipated to be required during the study period.
- Other Inclusion/Exclusion criteria may apply
Key Trial Info
Start Date :
December 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2019
Estimated Enrollment :
764 Patients enrolled
Trial Details
Trial ID
NCT03425825
Start Date
December 15 2016
End Date
January 24 2019
Last Update
January 26 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Barcelona, Spain, 08025
2
Local Institution
London, United Kingdom, N19JY